All Updates

DENVER, Colo.—Colorado gets mixed results for its policies and legislation to prevent cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN). In the latest edition of How Do You Measure Up?: A Progress Report on State Legislative Activity to

Salt Lake City – Utah falls short when it comes to implementing policies and passing legislation to fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN). According to the latest edition of How Do You Measure Up?: A

OLYMPIA, Wash.—Washington falls short on implementing policies and passing legislation to prevent and reduce cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN). The annual "How Do You Measure Up? A Progress Report on State Legislative Activity to Reduce Cancer

PORTLAND, Ore.—Oregon gets mixed results for implementing policies and passing legislation to prevent and reduce cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN). The annual "How Do You Measure Up? A Progress Report on State Legislative Activity to

SACRAMENTO, Calif. – California is falling short when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer according to a new cancer-fighting report released today. According to How Do You Measure Up? : A Progress Report on State Legislative Activity

Today the Senate Finance Committee is marking up the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, which includes a provision to cap Medicare beneficiaries’ out-of-pocket prescription drug costs in Medicare Part D, among several other proposed changes intended to bring down patient costs.

Washington, D.C. – Today the House Oversight and Reform Subcommittee on Economic and Consumer Policy is holding the first of two days of hearings examining JUUL’s role in the ongoing youth tobacco epidemic. The committee is examining JUUL’s role in the epidemic, its appeal to youth, its marketing practices and